Cellebrite DI (CLBT) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CLBT Stock Alerts $11.62 +0.09 (+0.78%) (As of 09:51 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cellebrite DI Short Interest DataCurrent Short Volume2,460,000 sharesPrevious Short Volume2,590,000 sharesChange Vs. Previous Month-5.02%Dollar Volume Sold Short$26.59 millionShort Interest Ratio / Days to Cover2.6Last Record DateApril 30, 2024Outstanding Shares205,930,000 sharesFloat Size61,290,000 sharesShort Percent of Float4.01%Today's Trading Volume40,353 sharesAverage Trading Volume859,929 sharesToday's Volume Vs. Average5% Short Selling Cellebrite DI ? Sign up to receive the latest short interest report for Cellebrite DI and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLBT Short Interest Over TimeCLBT Days to Cover Over TimeCLBT Percentage of Float Shorted Over Time Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Cellebrite DI Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,460,000 shares $26.59 million -5.0%4.0%2.6 $10.81 4/15/20242,590,000 shares $26.88 million +4.4%4.2%2.7 $10.38 3/31/20242,480,000 shares $27.48 million -5.3%4.5%2.5 $11.08 3/15/20242,620,000 shares $30.26 million +11.5%4.7%2.7 $11.55 2/29/20242,350,000 shares $28.13 million -0.4%4.4%2.4 $11.97 2/15/20242,360,000 shares $25.35 million -11.3%4.4%2.5 $10.74 Get the Latest News and Ratings for CLBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,660,000 shares $24.05 million +7.7%5.2%3 $9.04 1/15/20242,470,000 shares $20.23 million +1.2%4.9%2.9 $8.19 12/31/20232,440,000 shares $21.13 million +0.8%4.8%3.1 $8.66 12/15/20232,420,000 shares $19.94 million -13.3%4.8%3.3 $8.24 11/30/20232,790,000 shares $23.58 million +16.3%5.5%4.5 $8.45 11/15/20232,400,000 shares $19.20 million +2.6%4.7%4.4 $8.00 10/31/20232,340,000 shares $15.63 million -2.1%4.6%5.5 $6.68 10/15/20232,390,000 shares $16.78 million -7.7%4.7%6 $7.02 9/30/20232,590,000 shares $19.81 million +7.9%5.3%6.4 $7.65 9/15/20232,400,000 shares $17.74 million +1.7%4.9%5.9 $7.39 8/31/20232,360,000 shares $19.00 million +1.3%4.8%6.4 $8.05 8/15/20232,330,000 shares $17.89 million -5.3%4.8%6.9 $7.68 7/31/20232,460,000 shares $19.21 million +8.4%5.1%8.5 $7.81 7/15/20232,270,000 shares $15.84 million +0.9%4.7%9.3 $6.98 6/30/20232,250,000 shares $16.20 million +10.3%4.7%10.7 $7.20 6/15/20232,040,000 shares $12.99 million +1.0%4.2%10.9 $6.37 5/31/20232,020,000 shares $11.66 million -4.3%2.8%12.1 $5.77 5/15/20232,110,000 shares $11.63 million +0.5%2.9%13.8 $5.51 4/30/20232,100,000 shares $11.36 million -1.4%2.9%12.6 $5.41 4/15/20232,130,000 shares $12.23 million -3.2%3.1%10.3 $5.74 3/31/20232,200,000 shares $13.40 million +6.8%3.2%10.8 $6.09 3/15/20232,060,000 shares $11.87 million +0.5%3.0%7.8 $5.76 2/28/20232,050,000 shares $12.61 million -6.8%2.9%7.9 $6.15 2/15/20232,200,000 shares $12.98 million +8.9%3.2%8.9 $5.90 1/31/20232,020,000 shares $11.09 million +10.4%1.2%9.8 $5.49 1/15/20231,830,000 shares $8.03 million +2.2%1.1%10.3 $4.39 12/30/20221,790,000 shares $7.80 million +9.8%5.0%11.3 $4.36 12/15/20221,630,000 shares $6.98 million +14.8%4.5%11.5 $4.28 11/30/20221,420,000 shares $6.42 million -4.7%4.0%11.2 $4.52 11/15/20221,490,000 shares $7.38 million +5.7%4.2%12.4 $4.95 10/31/20221,410,000 shares $6.81 million -0.7%3.9%10.6 $4.83 10/15/20221,420,000 shares $6.06 million -11.3%4.0%9.8 $4.27 9/30/20221,600,000 shares $6.27 million -3.0%4.5%10.9 $3.92 9/15/20221,650,000 shares $7.36 million -4.6%4.6%12.2 $4.46Bill Gates is all about this tiny $2 stock (Ad)What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. CLBT Short Interest - Frequently Asked Questions What is Cellebrite DI's current short interest? Short interest is the volume of Cellebrite DI shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,460,000 shares of CLBT short. 4.01% of Cellebrite DI's shares are currently sold short. Learn More on Cellebrite DI's current short interest. What is a good short interest ratio for Cellebrite DI? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLBT shares currently have a short interest ratio of 3.0. Learn More on Cellebrite DI's short interest ratio. What is a good short interest percentage for Cellebrite DI? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.01% of Cellebrite DI's floating shares are currently sold short. Is Cellebrite DI's short interest increasing or decreasing? Cellebrite DI saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 2,460,000 shares, a drop of 5.0% from the previous total of 2,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cellebrite DI's float size? Cellebrite DI currently has issued a total of 205,930,000 shares. Some of Cellebrite DI's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellebrite DI currently has a public float of 61,290,000 shares. How does Cellebrite DI's short interest compare to its competitors? 4.01% of Cellebrite DI's shares are currently sold short. Here is how the short interest of companies in the sector of "business services" compare to Cellebrite DI: N-able, Inc. (1.47%), Jamf Holding Corp. (7.65%), Lightspeed Commerce Inc. (3.49%), Marqeta, Inc. (4.04%), AvePoint, Inc. (5.77%), Matterport, Inc. (2.58%), Coursera, Inc. (5.58%), MeridianLink, Inc. (4.25%), Sprinklr, Inc. (6.06%), Amplitude, Inc. (2.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cellebrite DI stock? Short selling CLBT is an investing strategy that aims to generate trading profit from Cellebrite DI as its price is falling. CLBT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellebrite DI? A short squeeze for Cellebrite DI occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLBT, which in turn drives the price of the stock up even further. How often is Cellebrite DI's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLBT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NABL Short Interest Data JAMF Short Interest Data LSPD Short Interest Data MQ Short Interest Data AVPT Short Interest Data MTTR Short Interest Data COUR Short Interest Data MLNK Short Interest Data CXM Short Interest Data AMPL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLBT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing